Cargando…
Update on Emerging Treatment Options for Primary Biliary Cholangitis
Primary biliary cholangitis (PBC) is a rare autoimmune cholestatic liver disease that may progress to fibrosis or cirrhosis. Treatment options are currently limited. Ursodeoxycholic acid (UDCA) remains first-line therapy and has been proven to normalize serum biochemistries, halt histologic disease...
Autores principales: | Aguilar, Maria T, Chascsa, David M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259454/ https://www.ncbi.nlm.nih.gov/pubmed/32547264 http://dx.doi.org/10.2147/HMER.S205431 |
Ejemplares similares
-
Update on the Pharmacological Treatment of Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022) -
An update on treatment options for primary sclerosing cholangitis
por: Iravani, Shahrokh, et al.
Publicado: (2020) -
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021) -
The Genetics of Primary Biliary Cholangitis: A GWAS and Post-GWAS Update
por: Hitomi, Yuki, et al.
Publicado: (2023) -
New treatments/targets for primary biliary cholangitis
por: Corpechot, Christophe, et al.
Publicado: (2019)